These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 7533703)

  • 41. Nifedipine GITS and hydrochlorothiazide in essential hypertension.
    Jueng C; Halperin AK; Hashimoto F; Callender K
    J Clin Hypertens; 1987 Dec; 3(4):695-703. PubMed ID: 3330992
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effectiveness of combination therapy with nifedipine GITS: a prospective, 12-week observational study (AdADOSE).
    Motaweih AK; Usova E; Hussain W; Dello Z; Schmidt B; Petri T
    BMC Cardiovasc Disord; 2015 May; 15():35. PubMed ID: 25956918
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effects of nifedipine GITS 20 mg or enalapril 20 mg on blood pressure and inflammatory markers in patients with mild-moderate hypertension.
    Agabiti Rosei E; Morelli P; Rizzoni D
    Blood Press Suppl; 2005 Jul; 1():14-22. PubMed ID: 16060412
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Nifedipine GITS replacing nifedipine SR: ambulatory blood pressure assessment of efficacy.
    Rahima-Maoz C; Grossman E; Nussinovitch N; Katz A; Rosenthal T
    Cardiology; 1997; 88 Suppl 3():43-6. PubMed ID: 9397293
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Equivalent reduction of proteinuria in hypertensives by either nifedipine GITS or enalapril: disparate effects on neurohormones and ambulatory blood pressure and the influence of salt.
    DeQuattro V; Lee DP
    Cardiology; 1997; 88 Suppl 3():38-42. PubMed ID: 9397292
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A comparison of the effects of two modified release preparations of nifedipine-nifedipine retard 10 mg twice daily and nifedipine GITS 20 mg once daily--in the treatment of mild to moderate hypertension.
    Kirby BJ; Kitchin NR
    Int J Clin Pract; 1999; 53(5):339-43. PubMed ID: 10695096
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Antihypertensive effectiveness of the nifedipine gastrointestinal therapeutic system.
    Gavras I; Mulinari R; Gavras H; Higgins JT; Reeves RL; Zawada ET; Crook J; Halperin AK; Garrett B
    Am J Med; 1987 Dec; 83(6B):20-3. PubMed ID: 3332575
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effects of doxazosin mesylate versus nifedipine on blood pressure variability in hypertensive patients: a randomized crossover study (SIMILAR).
    Shi J; Liang D; Pan Y; Zhang S; He M; Zhang H; Liu G; Gong Y; Wang W; Cang H; Li Y
    Blood Press Monit; 2019 Oct; 24(5):252-258. PubMed ID: 31116151
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Morning versus evening administration of nifedipine gastrointestinal therapeutic system in the management of essential hypertension.
    Greminger P; Suter PM; Holm D; Kobelt R; Vetter W
    Clin Investig; 1994 Nov; 72(11):864-9. PubMed ID: 7894213
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Combination therapy with nifedipine GITS 60 mg: subanalysis of a prospective, 12-week observational study (AdADOSE).
    Motaweih AK; Usova E; Hussain W; Dello Z; Petri T
    Clin Exp Hypertens; 2016; 38(1):71-80. PubMed ID: 26331311
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effect of lacidipine and nifedipine GITS on platelet function in patients with essential hypertension.
    Armas-Padilla MC; Armas-Hernández MJ; Hernández-Hernández R; Velasco M; Pacheco B; Carvajal AR; Castillo-Moreno A
    J Hum Hypertens; 2000 Apr; 14 Suppl 1():S91-5. PubMed ID: 10854087
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The nifedipine gastrointestinal therapeutic system (GITS). Evaluation of pharmaceutical, pharmacokinetic and pharmacological properties.
    Grundy JS; Foster RT
    Clin Pharmacokinet; 1996 Jan; 30(1):28-51. PubMed ID: 8846626
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effects of nifedipine GITS and diuretics in isolated systolic hypertension--a subanalysis of the INSIGHT study.
    Mancia G; Ruilope L; Palmer C; Brown M; Castaigne A; De Leeuw P; Rosental T; Wagener G
    Blood Press; 2004; 13(5):310-5. PubMed ID: 15545155
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Administration-time-dependent effects of doxazosin GITS on ambulatory blood pressure of hypertensive subjects.
    Hermida RC; Calvo C; Ayala DE; Domínguez MJ; Covelo M; Fernández JR; Fontao MJ; López JE
    Chronobiol Int; 2004 Mar; 21(2):277-96. PubMed ID: 15332347
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Study population and treatment titration in the International Nifedipine GITS Study: Intervention as a Goal in Hypertension Treatment (INSIGHT).
    Brown MJ; Castaigne A; de Leeuw PW; Mancia G; Rosenthal T; Ruilope LM
    J Hypertens; 1998 Dec; 16(12 Pt 2):2113-6. PubMed ID: 9886905
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effects of combination olmesartan medoxomil plus azelnidipine versus monotherapy with either agent on 24-hour ambulatory blood pressure and pulse rate in Japanese patients with essential hypertension: additional results from the REZALT study.
    Shimada K; Ogihara T; Saruta T; Kuramoto K;
    Clin Ther; 2010 May; 32(5):861-81. PubMed ID: 20685495
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Randomized trial comparing the effects of a low-dose combination of nifedipine GITS and valsartan versus high-dose monotherapy on central hemodynamics in patients with inadequately controlled hypertension: FOCUS study.
    Park JB; Ha JW; Jung HO; Rhee MY;
    Blood Press Monit; 2014 Oct; 19(5):294-301. PubMed ID: 24915052
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Trough:peak ratio of the blood pressure response to dihydropyridine calcium antagonists. Italian Nifedipine GITS Study Group.
    Zanchetti A
    J Hypertens Suppl; 1994 Nov; 12(8):S97-106. PubMed ID: 7707165
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Efficacy and safety of two different formulations of nifedipine (GITS) vs. slow release microgranules in patients with mild and moderate hypertension.
    Botero R; Aroca G; Asa G; González M
    J Hum Hypertens; 2002 Mar; 16 Suppl 1():S156-60. PubMed ID: 11986916
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Prazosin GITS vs atenolol in patients with hypertension and normal lipid profile: a randomized, controlled multicenter study. Hyderabad Hypertension Study Group.
    Joglekar SJ; Jaguste V; Nanivadekar AS
    J Assoc Physicians India; 1998; Suppl 1():41-51. PubMed ID: 11233386
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.